SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
Krishnaprasad Baby, Swastika Maity, Chetan Hasmukh Mehta, Akhil Suresh, Usha Y. Nayak, Yogendra Nayak
Topics & Concepts
LopinavirDrug repositioningIn silicoPharmacologyRepurposingTMPRSS2DrugMedicineVirtual screeningComputational biologyDrug discoveryBiologyCoronavirus disease 2019 (COVID-19)BioinformaticsInfectious disease (medical specialty)DiseaseBiochemistryInternal medicineGeneEcologySARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsCOVID-19 Clinical Research Studies